lobbying_activities: 1104705

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1104705	016e4081-2920-4625-92e6-1a5b1f5bbc7c	Q1	JUNKER & NAKACHI F/K/A JOEL JUNKER & ASSOCIATES	323956	NUFARM AMERICAS, INC.	2011	first_quarter	TAR	Joel R. Junker & Associates is retained by Nufarm Americas, Inc. to facilitate the passage of duty suspension bills HR 5346 (lmazapyr) & 5347 (metsulfuron-methyl) and the extension of duty suspension bills HR 5337 (Triphenylytin Hydroxide), 5338 (4-(2, 4-dichlorophenoxuyl) butyric acid (CAS NO. 94-82-6) and 4-(2, 4 dichlorophenoxyl) butyric acid, dimenthylamine salt), 5339 (Bromoxynil Octonoate), 5440 (dichloroprop-p acid, dichlorprop-p dimenthylamine salt, and dichlorprop-p (cont'd on next page) 2-ethylhexyl ester), 5341 (Gibberellic Acid), 5432 (2-methyl-4-chlorophenoxyacetic acid), 5433 (2-ethylhexyl (4-chloro-2-methylphenoxy) acetate). 5434 (2-Methyl-4-chlorophenoxyacetic acid, dimethylene salt) and 5345 (MCPB Acid and MCPB Sodium Salt). During the first through fourth quarters of 2009, Joel R. Junker made contact concerning all of the above-referenced bills.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2011-04-27T18:26:31.347000-04:00